Although most of the studies on KLF4 have focused on epithelial tumours, several studies have investigated the role of KLF4 in B cells and B cell malignancies and indicated that it is a tumour suppressor in non-Hodgkin’s lymphoma and a potential biomarker for inferior overall survival [16, 17]. This evidence concerns the gene KLF4 and non-Hodgkin lymphoma.